Barriers to antiretroviral adherence among HIV-infected adults

AIDS Patient Care and STDs

Volumn 14, Issue 1, 2000, Pages 47-58

  Murphy, Debra A ^a   Roberts, Kathleen Johnston ^a   Martin, David J ^b   Marelich, William ^a   Hoffman, Dannie ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b HARBOR UCLA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; ADEFOVIR DIPIVOXIL; ANTIRETROVIRUS AGENT; DELAVIRDINE; DIDANOSINE; EFAVIRENZ; ETHAMBUTOL; HYDROXYUREA; INDINAVIR; LAMIVUDINE; LAMIVUDINE PLUS ZIDOVUDINE; NELFINAVIR; RITONAVIR; SAQUINAVIR; STAVUDINE; ZIDOVUDINE;

ADULT; ARTICLE; CLINICAL ARTICLE; DOCTOR PATIENT RELATION; FEMALE; HEALTH CARE PERSONNEL; HEALTH CARE SYSTEM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERPERSONAL COMMUNICATION; MALE; PATIENT ATTITUDE; PATIENT COMPLIANCE; PATIENT SATISFACTION; SLEEP;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; ATTITUDE TO HEALTH; EDUCATIONAL STATUS; FEMALE; FOCUS GROUPS; HIV INFECTIONS; HUMANS; INCOME; MALE; MIDDLE AGED; PATIENT COMPLIANCE; SOCIAL SUPPORT;

EID: 0033959162     PISSN: 10872914     EISSN: None     Source Type: Journal    
DOI: 10.1089/108729100318127     Document Type: Article

References (24)

1. Ho DD, Neuman AU, Perelson AS, Chen W, Leonard JM, Markowitz M. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 1995;373:123-126.
2. Perelson AS, Neumann AU, Markowitz M, Leonard JM, Ho DD. HIV-1 dynamics in vivo: Virion clearance rate, infected cell life-span, and viral generation time. Science 1996;271:1582-1586.
3. Friedland GH. Adherence: The Achilles' heel of highly active antiretroviral therapy. In: Improving the management of HIV disease. International AIDS Society, 1997:13-15.
4. Ickovics JR, Meisler AW. Adherence in AIDS clinical trials: A framework for clinical research and clinical care. J Clin Epidemiol 1997;50:385-391.
5. Balestra P, Ferri F, Galgani S, et al. Clinical, psychological, and behavioral characteristics of HIV patients reporting low compliance to treatments. Presented at the XIth International Conference on AIDS; July 1996; Vancouver, British Columbia, Canada.
6. Chow R, Chin T, Fong IW, Bendayan R. Medication use patterns in HIV-positive patients. Can J Hosp Pharmacol 1993;46:171-175.
7. Singh N, Squier C, Sivek C, Wagener M, Nguyen MH, Yu VL. Determinants of compliance with antiretroviral therapy in patients with human immunodeficiency virus: Prospective assessment with implications for enhancing compliance. AIDS Care 1996;8: 261-269.
8. Roland ME. Antiviral adherence dilemmas. Focus 1998;13:1.
9. Bailey A, Ferguson E, Voss S. Factors affecting an individual's ability to administer medication. Home Healthcare Nurse 1995;13:57-63.
10. Farmer KC, Jacobs EW, Phillips CR. Long-term patient compliance with prescribed regimens of calcium channel blockers. Clin Ther 1994;16:316-326.
11. Jacobs J, Goldstein AG, Kelly ME, Bloom BS. NSAID dosing schedule and compliance [letter]. Drug Intell Clin Pharmacol 1988;22:727-728.
12. Samet JH, Libman H, Steger KA, et al. Compliance with zidovudine therapy in patients infected with human immunodeficiency virus, type 1: A cross-sectional study in a municipal hospital clinic. Am J Med 1992;92:495-502.
13. Sackett DL, Haynes RB. Compliance with therapeutic regimens. Baltimore, MD: Johns Hopkins University Press.
14. Haynes RB. Strategies to improve compliance with referrals, appointments, and prescribed medical regimens. In: Haynes RB, Taylor DW, Sackett DL, eds. Compliance on Health Care. Baltimore, MD: Johns Hopkins University Press; 1979:121-143.
15. Meichenbaum D, Turk DC. Treatment adherence: Terminology, incidence, and conceptualization. In: Meichenbaum D, ed. Facilitating Treatment Adherence: A Practitioner's Guidebook. New York, NY: Plenum Press; 1987:19-39.
16. Carney RM, Freedland KE, Eisen SA, Rich MW, Jaffe AS. Major depression and medication adherence in elderly patients with coronary artery disease. Health Psychol 1995;14:88-90.
17. Chesney M, Folkman S, Chambers D. Coping effectiveness training for men living with HIV: Preliminary findings. Int J STD AIDS 1996;7:75-82.
18. Hall JA, Roter DL, Katz NR. Meta-analysis of correlates of provider behavior in medical encounters. Med Care 1988;26:657-675.
19. Kaplan SH, Greenfield S, Ware JE Jr. Assessing the effects of physician-patient interactions on the outcomes of chronic disease. Med Care 1989;27:S110-127.
20. Chesney MA, Ickovics JR. ACTG Adherence Baseline Questionnaire [Questionnaire available online at: http://hivinsite.ucsf.edu/topics/adherence_compliance/self- report_adherence_instruments]. 1997.
21. Costanza RS, Derlega VJ, Winstead B A. Positive and negative forms of social support: Effects of conversational topics on coping with stress among same-sex friends. J Exp Soc Psychol 1988;24:182-193.
22. Murrell SA, Norris FH, Chipley QT. Functional versus structural social support, desirable events, and positive affect in older adults. Psychol Aging 1992; 7:562-570.
23. Brooks RA, Klosinski L. Assisting persons living with HIV/AIDS to return to work: Programmatic steps for AIDS Service Organizations. AIDS Educ Prev 1999;11: 212-223.
24. Brooks RA, Ortiz DJ, Veniegas RC, Martin DJ. Employment Issues Survey. Findings from a survey of employment issues affecting persons with HIV/AIDS living in Los Angeles County. Los Angeles, CA: L.A. County Department of Health Services. Office of AIDS Programs and Policy; 1999.